marketcaparena
Search

    GNPX

    Genprex, Inc.

    Company overview

    Market capitalization
    $2.30M
    Employees
    13
    Latest publication
    2026-09-29
    About Genprex, Inc.

    Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. It also develops REQORSA Gene Therapy in Mesothelioma, Ras Inhibitor Resistant NSCLC, other tumor suppressor genes, and Glioblastoma, which is in preclinical studies. Its three-lung cancer clinical programs have received a Fast Track Designation from the FDA for the treatment of that patient population, and SCLC program has received an FDA Orphan Drug Designation. The company's diabetes gene therapy comprises of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes, its GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body's immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. It has research agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive; New York University; UTHealth Houston; and University of Pittsburgh. The company also has a sponsored research agreement with The University of Texas MD Anderson Cancer Center to study biomarkers that for the prediction of patient response to Reqorsa Gene Therapy. Genprex, Inc. was incorporated in 2009 and is based in Austin, Texas.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue0USD0USD0USD0USD9,916USD0USD0USD0USD
    Research Development2,745,945USD2,196,351USD2,192,881USD2,499,495USD2,539,993USD2,838,464USD2,756,081USD1,666,522USD
    Selling General Administrative1,748,239USD1,322,282USD1,153,032USD2,182,289USD1,429,299USD1,496,803USD1,566,085USD4,849,472USD
    Total Operating Expenses4,494,184USD3,518,630USD3,345,913USD4,681,784USD3,969,292USD4,335,730USD4,322,166USD6,515,994USD
    Operating Income-4,494,184USD-3,518,630USD-3,345,913USD-4,681,784USD-3,969,292USD-4,335,730USD-4,323,438USD-6,518,282USD
    Interest Income31,748USD———4,771USD4,723USD8,080USD23,057USD
    Net Interest Income31,748USD-284,386USD-455,549USD—4,771USD4,723USD8,080USD23,057USD
    Income Before Tax-4,461,895USD-3,790,211USD-3,799,240USD-4,674,901USD-3,964,601USD-4,330,462USD-4,315,987USD-6,495,845USD
    Net Income-4,461,895USD-3,790,211USD-3,799,240USD-4,674,901USD-3,964,601USD-4,330,462USD-4,315,987USD-6,495,845USD
    Net Income From Continuing Ops-4,461,895USD-3,790,211USD-3,799,240USD-4,674,901USD-3,964,601USD-4,330,462USD-4,315,987USD-6,495,845USD
    Ebitda-4,494,184USD-3,505,825USD-3,343,691USD-4,681,784USD-3,967,619USD—-4,314,716USD-6,493,557USD
    Reconciled Depreciation0USD0USD0USD0USD0USD463USD1,272USD2,288USD
    Total Other Income Expense Net32,289USD-271,581USD-453,327USD6,883USD4,691USD545USD7,451USD22,437USD
    Selling And Marketing Expenses—3USD——————
    Interest Expense—284,386USD455,549USD———0USD—
    Ebit—12,451,987USD—-4,683,457USD-3,969,292USD-4,335,730USD-4,315,988USD-6,495,845USD
    Depreciation And Amortization—-3,346USD—1,673USD1,673USD—1,272USD2,288USD
    Cost Of Revenue————463USD—1,272USD2,288USD
    Gross Profit————-463USD—-1,272USD-2,288USD
    Income Tax Expense———————2USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue0USD0USD0USD0USD0USD0USD0USD0USD
    Research Development9,428,720USD10,535,446USD17,616,605USD11,510,074USD8,970,865USD7,302,923USD1,967,007USD971,427USD
    Selling General Administrative6,086,899USD10,632,028,000USD13,443,961USD12,295,070USD10,970,472USD10,635,881USD11,386,229USD11,386,229USD
    Total Operating Expenses15,515,619USD21,167,474USD31,060,566USD23,805,144USD20,647,568USD17,938,804USD10,669,603USD12,363,541USD
    Operating Income-15,515,619USD-21,174,167USD-31,075,570USD-23,830,719USD-20,670,102USD-17,961,581USD-10,682,673USD-12,363,541USD
    Interest Expense739,935USD0USD—18,108,235USD5,133USD0USD37,982USD37,982USD
    Net Interest Income-739,935USD63,574USD231,011USD90,098USD5,133USD18,811USD27,905USD-8,798USD
    Income Before Tax-16,228,953USD-21,111,163USD-30,860,461USD-23,740,621USD-20,664,969USD-17,942,770USD-10,654,768USD-12,372,339USD
    Net Income-16,228,953USD-21,111,163USD-30,860,461USD-23,740,621USD-20,664,969USD-17,942,770USD-10,654,768USD-12,372,339USD
    Net Income From Continuing Ops-16,228,953USD-21,111,163USD-31,454,808USD-23,740,621USD-19,595,624USD-17,942,770USD-10,654,768USD-12,372,339USD
    Ebitda-15,489,018USD-21,104,470USD-31,060,566USD-23,715,046USD-20,642,435USD-17,919,993USD-10,641,698USD-12,328,472USD
    Reconciled Depreciation0USD6,693USD17,656USD25,575USD22,534USD22,777USD13,070USD5,885USD
    Total Other Income Expense Net-713,334USD63,004USD215,109USD90,098USD5,133USD18,811USD27,905USD-8,798USD
    Cost Of Revenue—6,693USD15,004USD25,575USD22,534USD22,777USD13,070USD0USD
    Gross Profit—-6,693USD-15,004USD-25,575USD-22,534USD-22,777USD-13,070USD0USD
    Unclassified Operating Expenses—-10,621,395,972USD————-2,683,633USD—
    Interest Income—63,574USD231,011USD90,098USD5,133USD18,811USD27,905USD29,184USD
    Income Tax Expense—-21,367,170,837USD-4USD5,722,484USD-5,133USD-18,811USD29,184USD29,184USD
    Ebit—-21,111,163USD-31,075,570USD-23,740,621USD-20,664,969USD-17,942,770USD-10,654,768USD-12,334,357USD
    Depreciation And Amortization—6,693USD15,004USD25,575USD22,534USD22,777USD13,070USD5,885USD
    Net Income Applicable To Common Shares————-19,595,624USD-17,942,770USD-10,654,768USD-12,372,339USD
    Non Operating Income Net Other—————18,811USD27,905USD20,386USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets17,136,916USD20,306,266USD10,159,011USD3,562,513USD3,827,524USD6,009,687USD4,124,325USD3,907,265USD
    Cash And Equivalents15,154,203USD———————
    Total Current Assets15,842,835USD18,803,059USD8,356,783USD1,715,101USD2,056,184USD4,163,739USD2,077,467USD1,917,503USD
    Other Current Assets688,632USD753,804USD525,928USD611,786USD709,340USD695,401USD475,807USD429,222USD
    Other Non Current Assets1,294,081USD———————
    Total Liabilities2,341,864USD———————
    Total Current Liabilities2,341,864USD3,353,496USD2,174,635USD2,551,706USD2,436,329USD2,141,832USD2,504,170USD2,242,294USD
    Other Current Liabilities2,025,785USD———————
    Total Stockholder Equity14,795,052USD16,930,270USD7,961,876USD767,807USD1,391,195USD3,867,855USD1,620,155USD1,664,971USD
    Total Equity Including Noncontrolling Interest14,795,052USD———————
    Accounts Payable293,579USD1,655,028USD743,070USD1,619,446USD930,812USD1,525,684USD1,074,295USD1,304,121USD
    Common Stock506USD9,045USD3,291USD1,004USD33,145USD24,155USD—5,489USD
    Retained Earnings-179,937,510USD-175,490,291USD-171,028,396USD-167,238,185USD-163,438,946USD-158,764,044USD-154,799,443USD-150,468,981USD
    Total Liab—3,375,996USD2,197,135USD2,794,706USD2,436,329USD2,141,832USD2,504,170USD2,242,294USD
    Other Current Liab—1,698,468USD1,431,565USD932,260USD1,505,517USD616,148USD1,429,875USD938,173USD
    Capital Stock—9,045USD3,291USD1,004USD33,145USD24,155USD217USD5,489USD
    Cash—18,049,255USD7,830,855USD1,103,315USD1,346,844USD3,468,338USD1,601,660USD1,488,281USD
    Cash And Short Term Investments—18,049,255USD7,830,855USD1,103,315USD1,346,844USD3,468,338USD—1,488,281USD
    Net Debt—-18,049,255USD-7,830,855USD-1,103,315USD-1,346,844USD-3,468,338USD—-1,488,281USD
    Common Stock Shares Outstanding—6,951,999shares932,730shares760,502shares551,879shares305,305shares10,860,655shares69,996shares
    Non Current Assets Total—1,503,207USD1,802,228USD1,847,412USD1,771,340USD1,845,948USD2,046,858USD1,989,762USD
    Non Current Liabilities Total—22,500USD22,500USD243,000USD0USD0USD0USD0USD
    Non Currrent Assets Other—1,503,207USD1,802,228USD1,847,412USD1,771,340USD1,845,948USD2,046,858USD1,989,299USD
    Net Working Capital—15,449,563USD6,182,148USD-836,605USD-380,145USD2,021,907USD-426,703USD-324,791USD
    Unclassified Equity—192,402,471USD178,983,690USD168,003,984USD164,763,851USD162,583,589USD156,419,381USD152,122,974USD
    Property Plant Equipment Net——0USD———0USD463USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets10,159,011USD4,124,325USD10,670,592USD25,085,027USD42,862,286USD31,367,214USD3,534,229USD9,268,956USD
    Other Current Assets525,928USD475,807USD794,138USD519,076USD511,348USD384,553USD171,716USD236,851USD
    Total Liab2,197,135USD2,504,170USD3,254,208USD2,810,287USD1,585,295USD450,724USD510,684USD387,821USD
    Total Stockholder Equity7,961,876USD1,620,155USD7,416,384USD22,274,740USD41,276,991USD30,916,490USD3,023,545USD8,881,135USD
    Other Current Liab1,431,565USD1,429,875USD1,856,598USD2,367,362USD612,100USD257,756USD74,426USD387,821USD
    Common Stock3,291USD10,861USD1,486USD1,203USD47,874USD43,118USD19,264USD15,240USD
    Capital Stock3,291USD10,861USD1,486USD48,106USD47,874USD43,118USD19,264USD15,240USD
    Retained Earnings-171,028,396USD-154,799,443USD-133,688,279USD-102,827,000USD-79,087,198USD-58,422,229USD-40,479,459USD-29,824,691USD
    Cash7,830,855USD1,601,660USD6,737,629USD20,954,069USD38,628,876USD27,319,685USD2,002,492USD8,600,918USD
    Cash And Short Term Investments7,830,855USD1,601,660USD6,737,629USD20,954,069USD38,628,876USD27,319,685USD2,002,492USD8,600,918USD
    Total Current Assets8,356,783USD2,077,467USD7,531,767USD21,473,145USD39,140,224USD30,715,407USD2,976,643USD8,847,066USD
    Total Current Liabilities2,174,635USD2,504,170USD3,254,208USD2,810,287USD1,585,295USD450,724USD510,684USD387,821USD
    Net Debt-7,830,855USD-1,601,660USD-6,737,629USD-20,954,069USD-38,628,876USD-27,319,685USD-2,002,492USD-8,508,168USD
    Accounts Payable743,070USD1,074,295USD1,397,610USD442,925USD973,195USD192,968USD436,258USD295,069USD
    Property Plant Equipment Net0USD0USD7,859USD23,032USD48,608USD39,441USD44,654USD24,354USD
    Common Stock Shares Outstanding932,730shares80,119shares27,355shares23,977shares23,549shares17,761shares8,014shares13,771,020shares
    Non Current Assets Total1,802,228USD2,046,857USD3,138,825USD3,611,882USD3,722,062USD651,807USD557,586USD421,890USD
    Non Current Liabilities Total22,500USD0USD0USD442,925USD0USD0USD0USD0USD
    Non Currrent Assets Other1,802,228USD2,046,857USD2,357,488USD2,886,755USD3,031,094USD10,741USD21,732USD18,085USD
    Net Working Capital6,182,148USD-426,703USD4,277,559USD18,662,858USD37,554,929USD30,264,683USD2,465,959USD8,459,245USD
    Unclassified Equity178,983,690USD156,397,876USD141,101,691USD125,052,431USD120,268,441USD89,252,483USD43,464,476USD38,675,346USD
    Other Assets—1USD1USD—0USD612,366USD21,732USD18,085USD
    Short Term Investments—1,600,058,340USD——————
    Unclassified Current Assets—-1,600,058,340USD——————
    Intangible Assets——773,478USD702,095USD642,360USD601,625USD491,200USD379,451USD
    Net Receivables——0USD34,852USD0USD127USD655USD9,297USD
    Accumulated Other Comprehensive Income——0USD0USD————
    Net Tangible Assets————40,634,631USD30,314,865USD2,532,345USD8,501,684USD
    Inventory—————3,011,042USD801,780USD—
    Property Plant Equipment Gross—————39,441USD44,654USD24,354USD
    Short Term Debt——————74,430USD92,750USD
    Short Long Term Debt Total——————92,750USD92,750USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Change To Liabilities144,731USD
    Change In Working Capital-612,194USD
    Operating Cash Flow-8,277,156USD
    Financing Cash Flow15,600,504USD
    Change In Cash7,323,348USD
    End Cash Flow15,154,203USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-4,461,895USD-3,790,210USD-3,799,240USD-4,674,902USD-3,964,601USD-4,607,580USD-4,315,987USD-6,495,845USD
    Stock Based Compensation73,432USD38,689USD385,106USD89,948USD184,198USD302,837USD420,226USD2,063,953USD
    Other Non Cash Items73,432USD-100,721USD475,103USD365,553USD184,197USD0USD773,478USD773,478USD
    Change In Working Capital1,250,006USD-246,029USD136,859USD355,166USD-381,022USD157,732USD1,708,564USD-2,139,716USD
    Total Cash From Operating Activities-3,138,457USD-4,098,271USD-3,187,278USD-3,864,235USD-4,161,425USD-3,869,430USD-1,412,447USD-5,795,842USD
    Capital Expenditures-3USD-10USD-2USD-5USD-5USD0USD-16,988USD-16,988USD
    Free Cash Flow-3,138,460USD-4,098,264USD-3,187,280USD-3,864,235USD-4,161,430USD-3,869,430USD-1,412,447USD-5,778,854USD
    Total Cash From Financing Activities13,356,857USD10,825,811USD2,943,749USD1,742,741USD6,028,103USD3,982,810USD1,215,182USD20,762USD
    Issuance Of Capital Stock13,356,857USD10,825,811USD2,943,749USD1,742,741USD6,028,103USD3,982,810USD1,215,182USD20,762USD
    Change In Cash10,218,400USD6,727,540USD-243,529USD-2,121,494USD1,866,678USD113,379USD-970,743USD-5,758,091USD
    Begin Period Cash Flow7,830,855USD1,103,315USD1,346,844USD3,468,338USD1,601,660USD1,488,281USD2,459,024USD8,217,115USD
    End Period Cash Flow18,049,255USD7,830,855USD1,103,315USD1,346,844USD3,468,338USD1,601,660USD1,488,281USD2,459,024USD
    Other Cashflows From Financing Activities13,356,857USD21,540,404USD2,943,749USD—277,119,000USD—1,215,182USD16,989USD
    Unclassified Financing Cash Flow-13,356,857USD-21,540,404USD-2,943,749USD———-1,215,182USD—
    Depreciation—0USD0USD0USD463USD463USD1,272USD2,288USD
    Investments——0USD0USD0USD-1USD-773,478USD16,989USD
    Total Cashflows From Investing Activities————-1USD—-773,478USD16,989USD
    Dividends Paid————-277,119,000USD———
    Other Cashflows From Investing Activities————-1USD—-773,478USD16,989USD
    Change To Account Receivables—————0USD0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-16,228,953USD-21,111,163USD-30,860,461USD-23,740,621USD-19,590,491USD-17,942,770USD-10,654,768USD-12,372,339USD
    Depreciation0USD6,693USD15,004USD25,575USD22,534USD22,777USD13,070USD5,885USD
    Stock Based Compensation312,835USD3,302,982USD5,408,728USD4,731,944USD5,347,559USD4,246,186USD3,529,984USD5,435,382USD
    Other Non Cash Items739,935USD773,478USD989,538USD4,731,944USD3,537,796USD4,538,502USD3,406,293USD-9,012,097USD
    Change In Working Capital-135,026USD-121,078USD698,126USD1,204,138USD1,009,952USD-261,279USD192,993USD84,538USD
    Total Cash From Operating Activities-15,311,209USD-17,149,088USD-24,738,603USD-17,778,964USD-14,284,924USD-13,935,086USD-6,918,721USD-6,846,534USD
    Capital Expenditures0USD0USD-71,383USD-4USD-83,796USD-2,337,250USD-946,899USD-103,317USD
    Free Cash Flow-15,311,209USD-17,149,088USD-24,809,986USD-17,778,960USD-14,368,720USD-16,272,336USD-7,865,620USD-6,949,851USD
    Total Cash From Financing Activities21,540,404USD12,011,953USD10,593,377USD6,426USD25,677,911USD41,589,529USD1,267,194USD15,389,518USD
    Issuance Of Capital Stock21,540,404USD12,011,953USD10,598,039USD6,426USD25,677,911USD41,589,529USD1,267,194USD15,389,518USD
    Change In Cash6,229,195USD-5,135,969USD-14,216,440USD-17,674,807USD11,309,191USD25,317,193USD-6,598,426USD8,439,667USD
    Begin Period Cash Flow1,601,660USD6,737,629USD20,954,069USD38,628,876USD27,319,685USD2,002,492USD8,600,918USD161,251USD
    End Period Cash Flow7,830,855USD1,601,660USD6,737,629USD20,954,069USD38,628,876USD27,319,685USD2,002,492USD8,600,918USD
    Other Cashflows From Financing Activities21,540,404USD277,119,000USD-71,214USD97,731USD-83,796USD-2,337,250USD1,267USD-103,317USD
    Unclassified Financing Cash Flow-21,540,404USD————2,337,250USD——
    Change To Account Receivables—0USD34,852USD-34,852USD127USD528USD8,642USD-453USD
    Investments—1,166USD76,085USD97,731USD-83,796USD-2,337,250USD-946,899USD-103,317USD
    Total Cashflows From Investing Activities—1,166USD-71,214USD97,731USD-83,796USD-2,337,250USD-946,899USD-103,317USD
    Dividends Paid—-277,119,000USD——————
    Other Cashflows From Investing Activities—1,166USD169USD157,466USD0USD-2,209,262USD-81USD-80,882USD
    Change To Liabilities———0USD780,226USD-247,290USD122,863USD-443,143USD
    Unclassified Operating Cash Flow———-4,731,944USD-4,612,274USD-4,538,502USD-3,406,293USD9,012,097USD
    Sale Purchase Of Stock—————41,589,529USD1,267,194USD15,389,518USD
    Cash And Cash Equivalents Changes—————25,317,193USD-6,598,426USD8,439,667USD
    Unclassified Investing Cash Flow—————4,546,512USD——
    Change To Inventory——————46,809USD-231,457USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.